The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial
Open accessAbstract
AIMS/HYPOTHESIS: The aim of this multicentre, randomised, controlled crossover study was to determine the efficacy of adding continuous glucose monitoring (CGM) to insulin pump therapy (CSII) in type 1 diabetes. METHODS: Children and adults (n = 153) on CSII with HbA(1c) 7.5-9.5% (58.5-80.3 mmol/mol) were randomised to (CGM) a Sensor On or Sensor Off arm for 6 months. After 4 months' washout, participants crossed over to the other arm for 6 months. Paediatric and adult participants were separately electronically randomised through the case report form according to a predefined randomisation sequence in eight secondary and tertiary centres. The primary outcome was the difference in HbA(1c) levels between arms after 6 months. RESULTS: Seventy-seven participants were randomised to the On/Off sequence and 76 to the Off/On sequence; all were included in the primary analysis. The mean difference in HbA(1c) was -0.43% (-4.74 mmol/mol) in favour of the Sensor On arm (8.04% [64.34 mmol/mol] vs 8.47% [69.08 mmol/mol]; 95% CI -0.32%, -0.55% [-3.50, -6.01 mmol/mol]; p < 0.001). Following cessation of glucose sensing, HbA(1c) reverted to baseline levels. Less time was spent with sensor glucose <3.9 mmol/l during the Sensor On arm than in the Sensor Off arm (19 vs 31 min/day; p = 0.009). The mean number of daily boluses increased in the Sensor On arm (6.8 ± 2.5 vs 5.8 ± 1.9, p < 0.0001), together with the frequency of use of the temporary basal rate (0.75 ± 1.11 vs 0.26 ± 0.47, p < 0.0001) and manual insulin suspend (0.91 ± 1.25 vs 0.70 ± 0.75, p < 0.018) functions. Four vs two events of severe hypoglycaemia occurred in the Sensor On and Sensor Off arm, respectively (p = 0.40). CONCLUSIONS/INTERPRETATION: Continuous glucose monitoring was associated with decreased HbA(1c) levels and time spent in hypoglycaemia in individuals with type 1 diabetes using CSII. More frequent self-adjustments of insulin therapy may have contributed to these effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A1C is currently recognized as the key surrogate marker for the development of longterm diabetes complications in people with type 1 and type 2 diabetes and has been used the primary endpoint for many CGM studies (1; 3; 4; 6; 32; 33).”
From Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (2019) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A1C is currently recognized as the key surrogate marker for the development of longterm diabetes complications in people with type 1 and type 2 diabetes and has been used the primary endpoint for many CGM studies (1; 3; 4; 6; 32; 33).”
From Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (2019) · cites this paper as [33]
Experimental — accuracy not yet measuredIn the citing paper
“Reductions in HbA1c have been reported with CGM use in people on multiple daily injection (MDI) therapy,19 and continuous subcutaneous insulin infusion therapy,20 with reduced time spent in hypoglycemia,20 and improved hypoglycemia awareness.21”
From Increased Time in Range and Fewer Missed Bolus Injections After Introduction of a Smart Connected Insulin Pen (2020) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Standards of Medical Care in Diabetes
Power, D. V. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,676
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Self-citationStandards of medical care in diabetes—2011
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s011 · Cited by 2,880
Continuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Self-citationEffectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes
Bergenstal, R. M., Tamborlane, W. V., Ahmann, A., Buse, J. B., Dailey, G., Davis, S. N., Joyce, C., Peoples, T., Perkins, B. A., Welsh, J. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002853 · Cited by 894
(2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.193 · Cited by 653
Pickup, J. C., & Sutton, A. J. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02486.x · Cited by 630
Pickup, J. C., Freeman, S. C., & Sutton, A. J. (2011) · BMJ · doi:10.1136/bmj.d3805 · Cited by 541
Deiss, D., Bolinder, J., Riveline, J.-P., Battelino, T., Bosi, E., Tubiana-Rufi, N., Kerr, D., & Phillip, M. (2006) · Diabetes Care · doi:10.2337/dc06-1134 · Cited by 539
Self-citationEffect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes
Battelino, T., Phillip, M., Bratina, N., Nimri, R., Oskarsson, P., & Bolinder, J. (2011) · Diabetes Care · doi:10.2337/dc10-1989 · Cited by 496
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–493 of 493
La mesure continue du glucose : présent et avenir Mesure continue du glucose au long cours en 2012
Sola‐Gazagnes, A., & Riveline, J. (2012) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(12)70467-4 · Cited by 1
Personal CGMおよびProfessional CGMの測定精度の検討
宜樹, 楠., 勝野, 朋., 中江理絵, 渡邉佳穂里, 拓, 角., 越智, 史., 徳田八大, 隆文, 赤., 美内, 雅., 宮川, 潤., et al. (2015) · 糖尿病 · doi:10.11213/tonyobyo.58.715 · Cited by 1
¿De qué nos sirve evaluar las tendencias del perfil glucémico ambulatorio?
Izquierdo, E. S. (2014) · Avances en Diabetología · doi:10.1016/j.avdiab.2014.06.002 · Cited by 1
Auf dem Weg zum „Closed-loop“-System
Thomas, A., Heinemann, L., & Freckmann, G. (2014) · Der Diabetologe · doi:10.1007/s11428-013-1127-y · Cited by 1
Real-Time Continuous Glucose Monitoring in Children and Adolescents
Battelino, T., Dovč, K., & Bratina, N. (2014) · Frontiers in diabetes · doi:10.1159/000363481 · Cited by 1
Self-citationDiabetes Device Downloading: Benefits and Barriers Among Youth With Type 1 Diabetes
Palmer, B. A., Soltys, K., Zimmerman, M. B., Norris, A. W., Tsalikian, E., Tansey, M., & Pinnaro, C. T. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211059537 · Cited by 1
Ólafsdóttir, A. F., & Lind, M. (2023) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2023.1247616 · Cited by 1
Gölz, S., Mader, J. K., Bilz, S., Kenzler, J., & Danne, T. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01670-y · Cited by 1
Hypoglykämien bei Kindern und Jugendlichen mit Typ-1-Diabetes
Ziegler, R., & Kiess, W. (2013) · Der Diabetologe · doi:10.1007/s11428-012-0976-0 · Cited by 1
Type 1 Diabetes Care: It's Not All Technology
Reach, G. (2014) · Frontiers in diabetes · doi:10.1159/000363521 · Cited by 1
Psychosoziale Aspekte aktueller Diabetestechnologien
Lange, K. (2016) · Der Diabetologe · doi:10.1007/s11428-016-0159-5 · Cited by 1
Carić, B., Lalic, K. S., Marin, S., Stošić, L., & Popović‐Pejičić, S. (2017) · Scripta Medica · doi:10.18575/msrs.sm.e.17.07 · Cited by 1
Endothelial Glycocalyx Shedding in Pediatric Diabetic Ketoacidosis
Ning, R. (2018) · Scholarship@Western (Western University) · Cited by 1
Zelinska, N. (2020) · Ukrainian Journal of Pediatric Endocrinology · doi:10.30978/ujpe2020-4-39 · Cited by 1
Tiselko, A. V., Yarmolinskaya, M. I., Borovik, N. V., Suslova, S. V., Владимировна, М. Е., & Milutina, Y. P. (2020) · Russian Bulletin of Obstetrician-Gynecologist · doi:10.17116/rosakush20202006156 · Cited by 1
van Beers, C. A. J., & DeVries, J. H. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815583508 · Cited by 1
Ferrández, S. M. B., Gutiérrez, T. M., Ballarín, G. L., Lozano, M. F., & Francés, G. M. L. (2021) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2019.11.014 · Cited by 1
L'insulinothérapie au xxie siècle : une symphonie de plus en plus harmonieuse
Benhamou, P., Hanaire, H. P., & Renard, É. (2021) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(21)00179-6 · Cited by 1
(2021) · transcript Verlag eBooks · doi:10.1515/9783839448809 · Cited by 1
Moreno-Fernández, J., García-Seco, J. A., Virlaboa-Cebrian, R., Seco, A. M., Muñoz‐Rodríguez, J. R., & Romero, F. J. G. (2023) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2021.12.012 · Cited by 1
Canciani, G. N., Stewart, Z. A., & Murphy, H. R. (2017) · Wiley eBooks · doi:10.1002/9781119043805.ch16 · Cited by 1
Kontinuerlig subkutan glukosmätning vid diabetes
Johansson, U., Hanås, R., Olsson, P.-O., Olinder, A. L., Persson, M., Werkö, S. S., Jacobson, S., Heintz, E., Akcan, D., Granath, A., et al. (2013)
Kontinuierliche Glucosemessung bei erwachsenen Typ-I-Diabetes-Patienten
Heinemann, L., & Siegmund, T. (2013) · Der Diabetologe · doi:10.1007/s11428-013-1121-4
Update van de farmacotherapeutische opties bij diabetes op kinderleeftijd
Chiarelli, F., & Marcovecchio, L. (2014) · Nederlands Tijdschrift voor Diabetologie · doi:10.1007/s12467-014-0023-4
Andersen, H. U., Kjelmann, M., Wittrup, M., & Almdal, T. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700328
Contreras, I., & Vehı́, J. (2015) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2015.10.170
Miranda, L. G. (2013) · Americanae (AECID Library)
Veeze, H. J., & Geelhoed-Duijvestijn, N. (2013) · Nederlands Tijdschrift voor Diabetologie · doi:10.1007/s12467-013-0022-x
Sensor augmented pump（SAP）で管理を行った1型糖尿病合併妊娠の1例
中江理絵, 宜樹, 楠., 勝野, 朋., 渡邉佳穂里, 完山昌隆, 拓, 角., 俊宏, 松., 越智, 史., 徳田八大, 隆文, 赤., et al. (2015) · 糖尿病 · doi:10.11213/tonyobyo.58.818
Using CGM For Day-To-Day Insulin-Dosing Decisions
Edelman, S. V. (2016) · The Endocrine Society eBooks · doi:10.1210/mtp5.9781943550043.ch17
Regulatory Aspects of New Technology in Diabetes: Can Research Help Us?
de Beaufort, C. E., & Lehmann, B. (2016) · Springer eBooks · doi:10.1007/978-3-319-40242-0_16
Tauschmann, M., & Hovorka, R. (2016) · Springer eBooks · doi:10.1007/978-3-319-40242-0_14
Ce que la mesure en continu du glucose apporte à la pompe à insuline
Hanaire, H. P. (2016) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(16)30189-4
Aguilera, E., & Vázquez, F. (2017) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2017.02.001
Schoumacker-Ley, L., Duchesne, L., Cuny, T., Böhme, P., Benzirar, S., Fay, R., Ziegler, O., & Guerci, B. (2017) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(17)30034-2
Aguilera, E., & Vázquez, F. (2017) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2017.02.008
Miljković, V. (2018) · Биомедицинска истраживања · doi:10.7251/bii1801037b
Glycaemic control in pregnancies complicated by type 1 diabetes
Stewart, Z. A. (2017) · Apollo (University of Cambridge) · doi:10.17863/cam.23269
Continuous Glucose Monitoring: An Overview for Nurse Practitioners
Neeley, C., & Freeborn, D. (2018) · ScholarsArchive (Brigham Young University)
Continuous and flash glucose monitoring in diabetes
Morris, D. (2019) · Journal of Prescribing Practice · doi:10.12968/jprp.2019.1.sup3.s3
Optimizing Insulin Pump Therapy: Advanced Bolus Options
Carić, B., Vuković, B., & Lalic, K. S. (2019) · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · doi:10.1007/978-3-030-17971-7_50
Basal Insulin Adjustments and Continuous Glucose Monitoring During Exercise in Type 1 Diabetes
Zaharieva, D. P. (2018) · YorkSpace (York University)
Faradji, R. N., & Viadero, M. E. S. D. L. M. (2019) · Springer eBooks · doi:10.1007/978-3-030-11815-0_36
Neue Technologien in der Diabetestherapie
Serfling, G., Kalscheuer, H., Schmid, S. M., & Lehnert, H. (2019) · Der Internist · doi:10.1007/s00108-019-0654-z
Labunets, І. F., Rodnichenko, A. E., & Panteleymonova, T. (2019) · Fìzìologìčnij žurnal · doi:10.15407/fz65.05.003
Problem solving in type 1 diabetes for primary care nurses–part 2
Morris, D. (2019) · Independent Nurse · doi:10.12968/indn.2019.12.25
Problem solving in type 1 diabetes for primary care nurses
Morris, D. (2019) · Independent Nurse · doi:10.12968/indn.2019.9.4
Sharifi, A., McAuley, S. A., Horsburgh, J. C., Loh, M., Jenkins, A. J., MacIsaac, R. J., & O'Neal, D. N. (2014)
Ferrández, S. M. B., Gutiérrez, T. M., Larramona, G., Lozano, M. F., & Francés, G. M. L. (2020) · Revista Mexicana de Pediatría · doi:10.35366/93262
Clinical Studies on Efficacy of Continuous Glucose Monitoring
Cherubini, V. (2020) · Springer eBooks · doi:10.1007/978-3-030-42806-8_4
Uduku, C. N., Reddy, M., & Oliver, N. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816714-4.00007-7
Part I: Continuous glucose monitoring systems
Moorman, J. M. (2020) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1260
Dreval', A. V. (2021) · Aegitas publishing house eBooks · doi:10.47359/978-0-369-40455-8
Guerci, B., Maillard, C., Bardoulat, I., Fendri, S., Delval, C., & Woynar, S. (2021) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2021.06.003
Does HbA1c Remain the Most Important Therapeutic Target in Outpatient Management of Diabetes?
Gonzales, K. M., & Smith, S. (2021) · Wiley eBooks · doi:10.1002/9781119603207.ch8
Helmi, M. A. M., Norsa’adah, B., & Hussain, S. (2021) · Malaysian Journal of Paediatrics and Child Health · doi:10.51407/mjpch.v27i2.152
Diabetes Update 2014 – das spannendste Diabetes-Update aller Zeiten
Scherbaum, W. A. (2014) · Der Diabetologe · doi:10.1007/s11428-013-1190-4
1) Progression of the Advanced Technology and Therapy for Diabetes Mellitus
Matsuhisa, M., & Kuroda, A. (2021) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.110.420
Maltoni, G., & Zucchini, S. (2016) · Springer eBooks · doi:10.1007/978-3-319-40242-0_13
Metabolic control after years of completing a clinical trial on sensor-augmented pump therapy
Quirós, C., Giménez, M., Orois, A., & Conget, I. (2015) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2015.11.009
Self-citationType 1 diabetes: technology and transplants
FRCP, D. L. M. (2017) · Wiley eBooks · doi:10.1002/9781119052210.ch8
Moreno-Fernández, J., García-Seco, J. A., Virlaboa-Cebrian, R., Seco, A. M., Muñoz‐Rodríguez, J. R., & Romero, F. J. G. (2022) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2021.12.011
Empfehlungen zur Diabetes-Behandlung mit automatischen Insulin-Dosierungssystemen
Berge, T. V. D., Biester, S., Biester, T., Buchmann, A.-K., Datz, N., Grosser, U., Kapitzke, K., Klusmeier, B., Remus, K., Reschke, F., et al. (2022) · Diabetes aktuell · doi:10.1055/a-1851-2883
Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter
Neu, A., Bürger-Büsing, J., Danne, T., Dost, A., Holder, M., Holl, R. W., Holterhus, P., Kapellen, T. M., Karges, B., Kordonouri, O., et al. (2022) · Die Diabetologie · doi:10.1007/s11428-022-00936-y
Make room for continuous glucose monitoring in type 2 diabetes management
Schleich, K. T. (2022) · The Journal of Family Practice · doi:10.12788/jfp.0500
Il monitoraggio in continuo della glicemia: stato dell’arte
Irace, C., & Molfetta, S. D. (2022) · il Diabete · doi:10.30682/ildia2204g · Cited by 1
Jacobsen, L. M., Sherr, J. L., Considine, E. G., Chen, A., Peeling, S., Hulsmans, M., Charleer, S., Urazbayeva, M., Tosur, M., ALAMARIE, S. A., et al. (2023) · medRxiv · doi:10.1101/2023.04.15.23288624
Ehealth intervention to optimize adherence in late adolescents and young adults with type 1 diabetes
AlBurno, H. (2023) · Research Publications (Maastricht University) · doi:10.26481/dis.20240118ha
Eldar, O., Katzir, A., Bakal, L., Dori‐Dayan, N., Zemet, R., Mazaki‐Tovi, S., Cukierman‐Yaffe, T., Cohen, O., & Yoeli‐Ullman, R. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.111075
New Technologies for Insulin Administration
Forde, H. E., & Choudhary, P. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch33
Stars and Rising Stars in Pediatric Endocrinology: 2022
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-4686-4
Comité de Innovación. Uso de los sistemas de infusión continua de insulina en personas con DM1
Carnero, R., Saleme, A., Lequi, L., Daín, A., Campos, F. S., Sosa, L., Flores, A., & Kabakian, L. (2024) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v58i1sup.763
Ghawil, M., Issa, R., & Saed, S. (2024) · AlQalam Journal of Medical and Applied Sciences · doi:10.54361/ajmas.2472018
Chaubey, A., Chaubey, D., Dwivedi, A., Dwivedi, S., & Mishra, T. (2024) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1950_23
Tecnología aplicada a la diabetes
Cebada, A. B., Silva, J. B. Q., Escobar-Morreale, H. F., & Chávez, L. N. (2024) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2024.10.004
Haak, T., Fritsche, A., Füchtenbusch, M., Gehr, B., Gölz, S., Kröger, J., Siegmund, T., Ziegler, R., Droßel, D., Fuchs, S., et al. (2025) · Die Diabetologie · doi:10.1007/s11428-024-01280-z
Milad, K., Ghiath, S., & Sehaib, M. (2025) · Libyan Medical Journal · doi:10.69667/lmj.2517209
Eer, A., Hachem, M., Hearn, T., Koye, D. N., Atkinson‐Briggs, S., Jones, J. L., Eades, S., Braat, S., Twigg, S. M., Sinha, A. K., et al. (2025) · Pilot and Feasibility Studies · doi:10.1186/s40814-025-01607-7
Practical Applications of Wearable Devices for Diagnosis and Monitoring
Kim, H. (2024) · MechEcology · doi:10.23104/me.2024.10.3.2.23
Hsiung, K. S., Datye, K. A., & Schlundt, D. G. (2025) · Health Psychology Open · doi:10.1177/20551029251408544
A novel way to represent weekly blood sugar data to increase user understanding and control
Kyberd, P., Chadwell, A., Lee, M., & Safi, F. O. F. A. (2026) · Computer Methods in Biomechanics & Biomedical Engineering · doi:10.1080/10255842.2026.2645166
Haak, T., Fritsche, A., Füchtenbusch, M., Gehr, B., Gölz, S., Kröger, J., Siegmund, T., Ziegler, R., Droßel, D., Fuchs, S., et al. (2026) · Die Diabetologie · doi:10.1007/s11428-026-01467-6
Molveau, J. (2025) · theses.fr (ABES) · doi:10.70675/bd2bda54z3647z4fc4z9eebz1d71ad50a8b2
Long-term efficacy and safety of sensor-augmented pump for type 1 diabetes
Takagi, S., Miura, J., Takita, M., Mochizuki, S., Shimura, K., Hoshina, S., Takaike, H., & Babazono, T. (2026) · Diabetology International · doi:10.1007/s13340-026-00908-3
Beckers, M., Harvengt, A., Schoenmaeckers, G. D. V., Beckers, D., Boutsen, L., Mouraux, T., Gies, I., Staels, W., Vanbesien, J., & Lysy, P. A. (2026) · Diabetes & Metabolism · doi:10.1016/j.diabet.2026.101774
Sugar slay: a gamified decision support ecosystem for type 1 diabetes
Rengarajan, S., Abrams, N., Tabar, A., Sundaram, H., Singh, K. P., & Chukoskie, L. (2026) · Frontiers in Digital Health · doi:10.3389/fdgth.2026.1779790
Lavens, A., Philips, J., Block, C. E. M. D., Crenier, L., Oriot, P., Vandenbroucke, M., Tenoutasse, S., den Brinker, M., Aken, S. V., Nobels, F. R. E., et al. (2026) · Diabetes Technology & Therapeutics · doi:10.1177/15209156261464233
Widera, M., Owczarek, A. J., Kolonko, A., Kamińska, D., Świder, R., Król, R., Sekta, S., Więcek, A., & Ziaja, J. (2026) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfag168
Vita, F. D., Zampetti, S., Latino, A., Pieralice, S., Pantano, A. L., Tubili, C., D’Onofrio, L., Coraggio, L., Napoli, N., Ocejo, P. D. O., et al. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113470
New Therapeutic Approaches in Diabetes Treatment: Immune Interventions
Allen, L. A., Mahmood, Z. S., & Dayan, C. M. (2026) · Springer eBooks · doi:10.1007/978-3-032-24854-1_28
Therapie des Typ-1-Diabetes – Praxisempfehlung der DDG
Haak, T., Fritsche, A., Füchtenbusch, M., Gehr, B., Gölz, S., Kröger, J., Siegmund, T., Ziegler, R., Droßel, D., Fuchs, S., et al. (2026) · Diabetologie und Stoffwechsel · doi:10.1055/a-2884-8129
(2026) · ADA Clinical Compendia · doi:10.2337/db20261-33
Metadata
- Authors
- the SWITCH Study Group, Battelino, T., Conget, I., Olsen, B., Schütz-Fuhrmann, I., Hommel, E., Hoogma, R., Schierloh, U., Sulli, N., & Bolinder, J.
- Affiliations
- University of Ljubljana (SI)
- Glostrup Hospital (DK)
- Klinik Hietzing (AT)
- Groene Hart Ziekenhuis (NL)
- Centre Hospitalier de Luxembourg (LU)
- Karolinska University Hospital (SE)
- Corresponding author
- Battelino, T.
- Venue
- Diabetologia
- Published
- 2012-09-11
- Volume
- 55
- Issue
- 12
- Pages
- 3155-3162
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- PMC
- PMC3483098
- OpenAlex
- W2075474575
- Cited by
- 494
- References
- 22
- Citations by year
- 2026: 14 · 2025: 20 · 2024: 28 · 2023: 27 · 2022: 27 · 2021: 52 · 2020: 52 · 2019: 52 · 2018: 53 · 2017: 44 · 2016: 39 · 2015: 28 · 2014: 30 · 2013: 25 · 2012: 1
- FWCI
- 21.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Diabetologia (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion, cc-by-nc-sa)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- continuous glucose monitoring, type 1 diabetes, insulin pump therapy, artificial pancreas, HbA1c, glycemic control, hypoglycemia, bolus insulin, children and adults, crossover trial, cost-effectiveness, quality of life
- MeSH terms
- Adolescent, Adult, Aged, Blood Glucose, Child, Diabetes Mellitus, Type 1, Female, Humans, Hyperglycemia, Hypoglycemic Agents, Insulin, Insulin Infusion Systems, Male, Middle Aged, Monitoring, Physiologic, Blood Glucose Self-Monitoring, Biosensing Techniques, Treatment Outcome, Cross-Over Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
